Management of hand eczema. ICD-10-number: L20., L23., L24., L25., L30 [Management von handekzemen. ICD-10-ziffer: L20., L23., L24., L25., L30]

DC ElementWertSprache
dc.contributor.authorDiepgen, T.L.
dc.contributor.authorElsner, P.
dc.contributor.authorFartasch, M.
dc.contributor.authorJohn, S.M.
dc.contributor.authorKöllner, A.
dc.contributor.authorSchliemann, S.
dc.contributor.authorSkudlik, C.
dc.contributor.authorWorm, M.
dc.date.accessioned2021-12-23T16:29:36Z-
dc.date.available2021-12-23T16:29:36Z-
dc.date.issued2009
dc.identifier.issn1438776X
dc.identifier.urihttps://osnascholar.ub.uni-osnabrueck.de/handle/unios/16272-
dc.description.abstractHand eczema (HE) is one of the most frequent skin diseases. Eczema of the hands is not a homogenous disease entity, but instead occurs in various forms, and comprehensive differential diagnosis is often necessary. The disease can range in severity from very mild to chronic severe disease that can even prevent the patient from working for extended periods of time and may be refractory to treatment. Chronic hand eczema is very costly and involves significant impairment of the quality of life of the patient. Several therapy options are available, but the treatment of chronic hand eczema is often difficult and unsatisfactory. Therapy is complex and requires multimodal management. Large, high-quality, randomized controlled clinical studies on the effectiveness of even established therapy options are lacking. The following guideline provides a starting point for evidence-based approach to hand eczema, presenting the classification, diagnosis, prevention, therapy, and rehabilitation of this disease. © 2009 Dustri-Verlag Dr. Karl Feistle.
dc.language.isode
dc.publisherDustri-Verlag Dr. Karl Feistle
dc.relation.ispartofDermatologie in Beruf und Umwelt
dc.subjectalitretinoin, 5300-03-8
dc.subjectbetamethasone, 378-44-9
dc.subjectclioquinol, 130-26-7, 8057-20-3
dc.subjectclobetasol propionate, 25122-46-7
dc.subjectdesonide, 638-94-8
dc.subjectfluprednidene, 2193-87-5
dc.subjectfluprednidene acetate, 1255-35-2
dc.subjectmometasone furoate, 83919-23-7, 105102-22-5
dc.subjectalitretinoin
dc.subjectAllergic contact dermatitis
dc.subjectbetamethasone
dc.subjectcalcineurin inhibitor
dc.subjectchronic disease
dc.subjectclinical trial
dc.subjectclioquinol
dc.subjectclobetasol propionate
dc.subjectcontact dermatitis
dc.subjectcost benefit analysis
dc.subjectcyclosporin A
dc.subjectdesonide
dc.subjectDiagnositic
dc.subjectdifferential diagnosis
dc.subjectdisease classification
dc.subjectdisease severity
dc.subjectevidence based medicine
dc.subjectfluprednidene
dc.subjectfluprednidene acetate
dc.subjectglucocorticoid
dc.subjectHand eczema
dc.subjecthuman
dc.subjectIrritant contact dermatitis
dc.subjectirritant dermatitis
dc.subjectkeratolytic agent
dc.subjectmometasone furoate, atopic dermatitis
dc.subjectPatch test
dc.subjectpompholyx
dc.subjectpractice guideline
dc.subjectPrevention
dc.subjectPUVA
dc.subjectquality of life
dc.subjectreview
dc.subjectTherapy
dc.titleManagement of hand eczema. ICD-10-number: L20., L23., L24., L25., L30 [Management von handekzemen. ICD-10-ziffer: L20., L23., L24., L25., L30]
dc.typereview
dc.identifier.doi10.5414/dbp57046
dc.identifier.scopus2-s2.0-70349392665
dc.identifier.urlhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-70349392665&doi=10.5414%2fdbp57046&partnerID=40&md5=8eab065ac5070d130a3b2c5414d9f5eb
dc.description.volume57
dc.description.issue2
dc.description.startpage46
dc.description.endpage64
dcterms.isPartOf.abbreviationDermatol. Beruf Umwelt
crisitem.author.deptUniversität Osnabrück-
crisitem.author.orcid0000-0001-5406-9458-
crisitem.author.netidJoSw269-
Zur Kurzanzeige

Seitenaufrufe

9
Letzte Woche
0
Letzter Monat
2
geprüft am 01.06.2024

Google ScholarTM

Prüfen

Altmetric